FDA Food recall F-0070-2020
OXZGEN Performance 25 mg Hemp Derived CBD + Teacrine + BCAA Orange Flavored, 5 blast caps, 2.2 FL OZ
- FDA Food
- Class II
- terminated
- Published 2019-10-30
On 2019-10-30 the FDA classified a Class II recall of OXZGEN Performance 25 mg Hemp Derived CBD + Teacrine + BCAA Orange Flavored, 5 blast caps, 2.2 FL OZ by Hall Global, citing yellow #6 is not declared on ingredient label. Label claim for B2 is incorrect (contains 5 mg not 10 mg as stated).
Read the official FDA Food notice
| Agency | FDA Food |
|---|---|
| Recall number | F-0070-2020 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2019-09-25 |
| Published | 2019-10-30 |
| Last updated | 2026-09-13 11:50 UTC |
| Company | Hall Global |
| Distribution | n/a |
Product
OXZGEN Performance 25 mg Hemp Derived CBD + Teacrine + BCAA Orange Flavored, 5 blast caps, 2.2 FL OZ
Reason
Yellow #6 is not declared on ingredient label. Label claim for B2 is incorrect (contains 5 mg not 10 mg as stated).
Identifiers
| code_info | 10097902, 10186904, 10235905, and 10278906 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:50 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/food/enforcement.json?search=recall_number:%22F-0070-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.